IC-265 / IACTA Pharma, Zhaoke Ophthalmology - LARVOL DELTA

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants (clinicaltrials.gov) - P2 | N=40 | Terminated | Sponsor: Iacta Pharmaceuticals | In an over abundance of caution the study was terminated. All adverse events resolved with no sequelae.

Trial completion date • Trial primary completion date • Trial termination • Dry Eye Disease • Ophthalmology

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants (clinicaltrials.gov) - P2 | N=40 | Recruiting | Sponsor: Iacta Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Dry Eye Disease • Ophthalmology

A Study to Assess Adverse Events and Change in Disease Activity of IC265 Ophthalmic Solution for Dry Eye in Adult Participants (clinicaltrials.gov) - P2 | N=40 | Not yet recruiting | Sponsor: Iacta Pharmaceuticals

Adverse events • New P2 trial • Dry Eye Disease • Ophthalmology